Main > ONCOLOGY (**) > Skin Cancer>Melanoma>MET *** > Treatment > Co: USA. M. PembrulizuMAb. ***

---

Co: USA. M. PembrulizuMAb. ***'s subsections
(*) EU Approval Date: 2015. 07.22.
(*) USA Approval Date: 2015. 12.18.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2019. 12.31
TradeMark
TradeMark Web-Site

Co: USA. M. PembrulizuMAb. ***'s products
This section has no products